Skip to Main Content

Paper Details

Effectiveness of the CoronaVac vaccine in older adults during a gamma variant associated epidemic of covid-19 in Brazil: test negative case-control study.
BMJ
202
2021
PARTICIPANTS, SARS-CoV, SARS-CoV-2, covid, covid-19, gamma, gamma variant
Aged, Aged, 80 and over, Brazil, COVID-19, COVID-19 Nucleic Acid Testing, COVID-19 Vaccines, Case-Control Studies, Female, Humans, Male, SARS-CoV-2, Treatment Outcome
Author NameAffiliation
Otavio T RanzaniBarcelona Institute for Global Health
Otavio T RanzaniHeart Institute (InCor), Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo
Murilo DorionYale School of Public Health
Tatiana Lang D'Agostini
Regiane Cardoso de Paula
Olivia Ferreira Pereira de Paula
Edlaine Faria de Moura VillelaMunicipal Health Secretary of Manaus
Mario Sergio Scaramuzzini TorresMunicipal Health Secretary of Manaus
Silvano Barbosa de Oliveira
Silvano Barbosa de OliveiraUniversidade de Brasilia
Wade Schulz (CM4AI)Yale University School of Medicine
Maria Almiron
Rodrigo Said
Roberto Dias de OliveiraState University of Mato Grosso do Sul - UEMS
Patricia Vieira da SilvaUniversidade Federal de Mato Grosso do Sul - UFMS
Wildo Navegantes de Ara??jo
Wildo Navegantes de Ara??joUniversidade de Brasilia
Wildo Navegantes de Ara??joNational Institute for Science and Technology for Health Technology Assessment
Jean Carlo Gorinchteyn
Jason R AndrewsStanford University
Derek A T CummingsUniversity of Florida
Derek A T CummingsEmerging Pathogens Institute, University of Florida
Albert I KoYale School of Public Health
Albert I KoInstituto Goncalo Moniz
Julio CrodaYale School of Public Health
Julio CrodaUniversidade Federal de Mato Grosso do Sul - UFMS
Julio Croda
  • 1 - 27

Datasets

Release 1.2